Lawsuit Overview
September 23, 2013 (Shareholders Foundation) - An investor, who currently hold shares of Cornerstone Therapeutics, Inc. (NASDAQ:CRTX) filed a lawsuit in effort to halt the proposed takeover of Cornerstone Therapeutics, Inc. by Chiesi Farmaceutici SpA for $9.50 per NASDAQ:CRTX share. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:CRTX stockhol...
You must register (for free) or login to view the entire case.